ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 704637 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 704637; 2) Community: the network communities that were significantly associated with the response to NSC 704637; 3) Molecule: the relationships between components within communities and NSC 704637; 4) MDR: the compounds that were significantly associated with the NSC 704637.

NSC Compound Enrichment Correlation
NSC 29422 Guanosine, 6-thio- (9CI) 0.0199123109106642 0.31881295
NSC 62485 Null 0.0199123109106642 0.26922498
NSC 658143 2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin 0.0209467683758283 0.15883889
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0209467683758283 0.39388687
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0209467683758286 0.34191533
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0209467683758286 0.1236339
NSC 18805 .gamma.-Thujaplicine 0.0209467683758286 0.29330392
NSC 300289 Pinafide 0.0209467683758286 0.37425919
NSC 332488 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)- 0.0209467683758286 0.33199656
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0209467683758286 0.24044091
Total:86  Current:43    [First] [Prev] [Next] [Last]